Targeting integrin pathways: mechanisms and advances in therapy

Short summary

Integrins, crucial cell-adhesion receptors, are complex therapeutic targets with only seven drugs successfully marketed despite 40 years of research. However, approximately 90 new integrin-based therapies are currently in clinical studies.

AI-generated from the title and abstract; the full text is not read.